Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 603896.SS

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) on January 27, 2025: 1.79

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Price to Book Ratio (P/B) is 1.79 on January 27, 2025, a -29.12% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 52-week high Price to Book Ratio (P/B) is 2.61 on February 27, 2024, which is 46.07% above the current Price to Book Ratio (P/B).
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 52-week low Price to Book Ratio (P/B) is 1.71 on September 18, 2024, which is -4.34% below the current Price to Book Ratio (P/B).
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 2.12.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 603896.SS

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

CEO	Mr. Zhen-Yu Li
IPO Date	May 10, 2017
Location	China
Headquarters	No. 12, Huanglong Third Road
Employees	1,143
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale, crocus sativus, and other health products. The company was founded in 1997 and is based in Jinhua, China.

Key trends

Past 5 years